Business Description
![AREV Life Sciences Global Corp AREV Life Sciences Global Corp logo](https://static.gurufocus.com/logos/0C00000KUB.png?14)
AREV Life Sciences Global Corp
NAICS : 325412
SIC : 3741
ISIN : CA04016C1077
Description
AREV Life Sciences Global Corp is a fully integrated, early stage life science discovery enterprise dedicated to delivering solutions to public healthcare metrics through innovations and successful collaborations in the life science industry. The Company's focuses on dedication to generate revenue by way of novel therapeutic approaches to human nutrition and malnutrition, pandemic diseases, and neglected chronic co-morbidities.
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.01 | |||||
Equity-to-Asset | -5.46 | |||||
Debt-to-Equity | -0.13 | |||||
Debt-to-EBITDA | -0.88 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -127.17 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -55 | |||||
3-Year EBITDA Growth Rate | 49.5 | |||||
3-Year EPS without NRI Growth Rate | 48.1 | |||||
3-Year FCF Growth Rate | 31.3 | |||||
3-Year Book Growth Rate | 18.8 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
12-1 Month Momentum % | -28 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.05 | |||||
Quick Ratio | 0.05 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -49.4 | |||||
Shareholder Yield % | -1.16 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -3014.29 | |||||
Net Margin % | -3414.29 | |||||
FCF Margin % | -2785.71 | |||||
ROA % | -89.58 | |||||
ROIC % | -80.05 | |||||
ROC (Joel Greenblatt) % | -132.32 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 45 | |||||
EV-to-EBIT | -12.23 | |||||
EV-to-EBITDA | -17.42 | |||||
EV-to-Revenue | 410.57 | |||||
EV-to-FCF | -14.74 | |||||
Earnings Yield (Greenblatt) % | -8.18 | |||||
FCF Yield % | -6.87 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
AREV Life Sciences Global Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil C$) | 0.007 | ||
EPS (TTM) (C$) | -0.015 | ||
Beta | 2.83 | ||
Volatility % | 28 | ||
14-Day RSI | 0 | ||
14-Day ATR (C$) | 0.000007 | ||
20-Day SMA (C$) | 0.09 | ||
12-1 Month Momentum % | -28 | ||
52-Week Range (C$) | 0.09 - 0.175 | ||
Shares Outstanding (Mil) | 31.76 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
AREV Life Sciences Global Corp Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
AREV Life Sciences Global Corp Stock Events
Event | Date | Price(C$) | ||
---|---|---|---|---|
No Event Data |
AREV Life Sciences Global Corp Frequently Asked Questions
What is AREV Life Sciences Global Corp(XCNQ:AREV)'s stock price today?
The current price of XCNQ:AREV is C$0.09. The 52 week high of XCNQ:AREV is C$0.18 and 52 week low is C$0.09.
When is next earnings date of AREV Life Sciences Global Corp(XCNQ:AREV)?
The next earnings date of AREV Life Sciences Global Corp(XCNQ:AREV) is .
Does AREV Life Sciences Global Corp(XCNQ:AREV) pay dividends? If so, how much?
AREV Life Sciences Global Corp(XCNQ:AREV) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |